Developer docs
API playgroundTry for free, no card

Search company profiles

Marwood Group

Full company profile

uuid00075jf

Namestring
Marwood Group
Legal namestring
Marwood Group & Co. USA, LLC
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Marwood Group is a privately held healthcare-focused strategic advisory and consulting firm founded in 2000 and headquartered in New York City, with additional offices in Washington D.C. (serving as a regulatory and policy hub) and London (via wholly owned subsidiary Marwood UK Ltd.). The firm serves four primary customer segments: private equity and financial sponsors, specialty and commercial lenders, healthcare companies (providers, payors, HIT, life sciences, and outsourcing), and asset managers and institutional investors. Its work centers on the intersection of government policy, reimbursement regulation, and market dynamics, areas where the firm's senior professionals (averaging 20+ years of healthcare experience) and ex-government bench (former White House, CMS, FDA, House Ways & Means, and state Medicaid officials) provide specialized judgment.

The firm operates three core service pillars — Transaction Support (buy-side and sell-side M&A due diligence across healthcare), Value Creation (portfolio-level policy, operational, and strategic advisory), and Retained Services (subscription-style ongoing access to subject matter experts, catalyst tracking, and policy monitoring). Underlying these pillars is a proprietary data module consisting of nearly 12 billion provider and payor claims across commercial, Medicare, and Medicaid, refreshed quarterly, which supports code-specific benchmarking, state-level profiling, and growth opportunity assessments. Adjacent capabilities include Life Sciences & HealthTech advisory, Global Insights (UK/EU and broader international coverage), Clinical Quality & Compliance, Performance Improvement, and Financial Advisory delivered through a FINRA- and SIPC-member broker-dealer affiliate (Marwood Group LLC).

Marwood's go-to-market is relationship-led and senior-led, driven by thought leadership content (the Healthcare Report newsletter reaching 90,000+ subscribers, whitepapers, webinars, and podcast appearances) and active sponsorship of marquee healthcare investment conferences including the JPM Healthcare Conference, HLTH, Kayo Healthcare PE Summit, ViVE, DHIS, and HPE Miami. The firm reports $500B+ in transaction value supported, 5,000+ cumulative engagements, 1,000+ investor and corporate clients, and coverage of 100+ healthcare sub-sectors. Pricing is not publicly disclosed and operates on custom engagement structures combining transaction-based advisory fees and retainer-based recurring subscriptions.

Short descriptiontext

Marwood Group is a healthcare-focused advisory firm providing M&A due diligence, value creation, and retained policy and reimbursement advisory to private equity firms, lenders, healthcare companies, and institutional investors, supported by a proprietary 12 billion-claim dataset.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWashington, United States
HQ citystring
Washington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare advisory services, transaction due diligence, healthcare policy consulting, value creation advisory, medical claims analytics
NAICS code3 codes
  • Other Management Consulting Services541618
  • Management Consulting Services54161
  • Portfolio Management and Investment Advice52394
SIC code2 codes
  • Services-Management Consulting Services8742
  • Investment Advice6282
Product category
Healthcare Advisory Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Transaction Support Advisory
TypeProfessional Services
Description

Due diligence and advisory services for buy-side and sell-side healthcare M&A and financing transactions across provider, payor, HIT, life sciences and broader healthcare services sectors.

marwoodgroup.com
2Retained Services
TypeSubscription Recurring
Description

Retainer-based advisory services providing real-time access to subject matter experts, policy and reimbursement trend analysis, on-demand insights, published research, and catalyst tracking for lenders, private equity, institutional investors and healthcare companies.

marwoodgroup.com
3Value Creation Services
TypeProfessional Services
Description

Strategic advisory services for healthcare corporations and investors including policy analysis, market strategy, reimbursement consulting, compliance assessments, and operational performance improvement.

marwoodgroup.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Marwood Group is a healthcare-focused advisory and consulting firm that delivers transaction support (buy-side and sell-side due diligence for healthcare M&A and financing), value creation (policy, market strategy, reimbursement, compliance, and operational advisory), and retained services (ongoing expert access, policy tracking, and on-demand insights) to private equity firms, healthcare companies, lenders, and institutional investors. Advisory work is grounded in a proprietary claims-based data module covering nearly 12 billion provider and payor records and supported by former government officials and industry operators with 20+ years of experience.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • $500B+ in transaction value supported
+3 more records
Product overview1 text field

Marwood Group is a healthcare advisory firm offering a comprehensive suite of consulting services organized around three core pillars: Transaction Support (due diligence for M&A), Value Creation (strategic advisory), and Retained Services (ongoing expert access). The firm's focus areas span Healthcare Policy, Market Research, Business Intelligence & Advanced Analytics (with a proprietary dataset of nearly 12 billion claims), Clinical Quality & Compliance, Performance Improvement, Life Sciences & HealthTech, Global Insights, and Financial Advisory (via its FINRA-registered affiliate). The firm also publishes The Healthcare Report (HCR), a curated newsletter reaching over 90,000 readers. These services are delivered by former government officials, healthcare operators, investment bankers, and industry experts to serve healthcare companies, private equity firms, lenders, and institutional investors.

Product and service12 records
1Transaction Support
CategoryHealthcare Advisory - Transaction Services
Description

Due diligence and advisory services for buy-side and sell-side M&A and financing transactions across the healthcare spectrum, supporting over $500B in transactions. Targeted at private equity firms, lenders, and healthcare companies evaluating or executing healthcare deals.

2Value Creation
CategoryHealthcare Advisory - Strategic Consulting
Description

Strategic advisory services combining healthcare policy expertise with operational and primary research capabilities to assess the healthcare industry and support portfolio companies. Targeted at healthcare corporations and investors seeking post-transaction value creation.

3Retained Services
CategoryHealthcare Advisory - Subscription Research
Description

Real-time access to dedicated subject matter experts and industry analysts for lenders, private equity, institutional investors, and healthcare companies, including policy tracking and risk management support on a recurring subscription basis.

4Healthcare Policy Advisory
CategoryHealthcare Advisory - Policy Focus Area
Description

Federal and state legislative and regulatory action analysis across all healthcare subsectors, staffed by former White House, executive branch agency, senior congressional staff and senior state Medicaid officials.

5Market Research
CategoryHealthcare Advisory - Research Focus Area
Description

Integrated market research combining deep healthcare policy knowledge with primary research capabilities using a proprietary network of stakeholders across the healthcare spectrum.

6Business Intelligence & Advanced Analytics
CategoryHealthcare Advisory - Analytics Focus Area
Description

Proprietary data module consisting of claims-based information with nearly 12 billion provider and payor claims across commercial, Medicare, and Medicaid, updated quarterly, providing code-specific benchmarking, reimbursement analyses, state-level profiles, and growth opportunity assessments for clients.

7Clinical Quality & Compliance
CategoryHealthcare Advisory - Compliance Focus Area
Description

Clinical compliance assessments, consulting services, and revenue cycle management functionality assessments conducted by clinicians, former healthcare operators, and certified coding experts.

8Performance Improvement
CategoryHealthcare Advisory - Operations Focus Area
Description

Revenue enhancement, cost reduction, and operational transformation services for healthcare providers, including revenue cycle management optimization and billing system improvements.

9Life Sciences & HealthTech
CategoryHealthcare Advisory - Life Sciences Focus Area
Description

Strategic guidance for investors, service providers, developers, and manufacturers of emerging healthcare innovations, including regulatory, reimbursement, and commercial strategy services.

10Global Insights
CategoryHealthcare Advisory - International Focus Area
Description

Multinational policy and market insights focusing on UK and EU regulatory, funding, and reimbursement dynamics, with international team members from Department of Health, NHS England, and private health insurers.

11Financial Advisory
CategoryHealthcare Advisory - Broker-Dealer Services
Description

Strategic transaction evaluation and execution through affiliate Marwood Group LLC, a FINRA-registered broker-dealer and state-registered investment adviser.

12The Healthcare Report (HCR) Newsletter
CategoryHealthcare Advisory - Content & Research Subscriptions
Description

Marwood's curated healthcare newsletter with over 90,000 healthcare executives, thought leaders and stakeholders, providing coverage of trends, advancements, and insights across major healthcare segments.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Healthcare-focused strategy and management consulting firm serving providers, payers, and investors across M&A, value-based care and performance improvement. Direct overlap with Marwood's healthcare advisory and value creation practices.

TypeDirect peer
Description

Boutique consultancy focused on healthcare providers, payers and integrated delivery systems, advising on strategy, M&A, reimbursement and performance. Highly comparable to Marwood's provider/payer transaction support and value creation work.

TypeDirect peer
Description

Specialist advisor to healthcare organizations and investors on strategy, M&A and performance, with deep provider and capital markets expertise. Closely comparable to Marwood's M&A diligence and value creation offerings.

TypeDirect peer
Description

Large advisory firm with a substantial healthcare practice serving providers, payers and life sciences clients on strategy, operations and M&A. Comparable in healthcare depth, larger in scale with broader public-sector reach.

TypeBroad incumbent
Description

Global management consulting and analytics firm specializing in life sciences and healthcare, with proprietary data assets and operations/policy work. Overlaps with Marwood in healthcare advisory, life sciences and data-driven diligence.

TypeBroad incumbent
Description

Global consulting firm with a large healthcare and life sciences practice advising payers, providers and investors on strategy, M&A and risk. Overlaps Marwood on healthcare transaction advisory but at far broader scale and across multiple sectors.

TypeBroad incumbent
Description

Top-tier global consultancy with a dedicated healthcare practice advising PE sponsors, payers, providers and pharma on strategy and M&A. Competes with Marwood for healthcare strategy and diligence mandates but offers much larger global staffing.

TypeDirect peer
Description

US consulting firm with a strong healthcare practice covering strategy, operations and performance improvement for providers, payers and life sciences companies. Comparable in healthcare advisory focus and ability to support transaction-related workstreams.

TypeBroad incumbent
Description

Top-tier global consultancy with a deep healthcare practice serving PE sponsors, payers, providers and pharma on strategy, diligence and value creation. Substantially larger than Marwood and competes on the largest healthcare mandates.

TypeEmerging player
Description

Specialized economic, financial and healthcare analytics firm providing expert analysis for transactions, disputes and policy. Comparable to Marwood on healthcare-oriented analytics and testimony, though a much broader economics-rooted platform.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles20 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Marwood Group

Healthcare Advisory Servicesmarwoodgroup.com

Marwood Group is a healthcare-focused advisory firm providing M&A due diligence, value creation, and retained policy and reimbursement advisory to private equity firms, lenders, healthcare companies, and institutional investors, supported by a proprietary 12 billion-claim dataset.

What Marwood Group does

Marwood Group is a privately held healthcare-focused strategic advisory and consulting firm founded in 2000 and headquartered in New York City, with additional offices in Washington D.C. (serving as a regulatory and policy hub) and London (via wholly owned subsidiary Marwood UK Ltd.). The firm serves four primary customer segments: private equity and financial sponsors, specialty and commercial lenders, healthcare companies (providers, payors, HIT, life sciences, and outsourcing), and asset managers and institutional investors. Its work centers on the intersection of government policy, reimbursement regulation, and market dynamics, areas where the firm's senior professionals (averaging 20+ years of healthcare experience) and ex-government bench (former White House, CMS, FDA, House Ways & Means, and state Medicaid officials) provide specialized judgment.

The firm operates three core service pillars — Transaction Support (buy-side and sell-side M&A due diligence across healthcare), Value Creation (portfolio-level policy, operational, and strategic advisory), and Retained Services (subscription-style ongoing access to subject matter experts, catalyst tracking, and policy monitoring). Underlying these pillars is a proprietary data module consisting of nearly 12 billion provider and payor claims across commercial, Medicare, and Medicaid, refreshed quarterly, which supports code-specific benchmarking, state-level profiling, and growth opportunity assessments. Adjacent capabilities include Life Sciences & HealthTech advisory, Global Insights (UK/EU and broader international coverage), Clinical Quality & Compliance, Performance Improvement, and Financial Advisory delivered through a FINRA- and SIPC-member broker-dealer affiliate (Marwood Group LLC).

Marwood's go-to-market is relationship-led and senior-led, driven by thought leadership content (the Healthcare Report newsletter reaching 90,000+ subscribers, whitepapers, webinars, and podcast appearances) and active sponsorship of marquee healthcare investment conferences including the JPM Healthcare Conference, HLTH, Kayo Healthcare PE Summit, ViVE, DHIS, and HPE Miami. The firm reports $500B+ in transaction value supported, 5,000+ cumulative engagements, 1,000+ investor and corporate clients, and coverage of 100+ healthcare sub-sectors. Pricing is not publicly disclosed and operates on custom engagement structures combining transaction-based advisory fees and retainer-based recurring subscriptions.

Marwood Group firmographics

Firmographics
Name
Marwood Group
Legal name
Marwood Group & Co. USA, LLC
Website
https://marwoodgroup.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
101–250 employees
Short description
Marwood Group is a healthcare-focused advisory firm providing M&A due diligence, value creation, and retained policy and reimbursement advisory to private equity firms, lenders, healthcare companies, and institutional investors, supported by a proprietary 12 billion-claim dataset.
Ownership category
akta.pro rank

Where Marwood Group is headquartered

Location

Headquarters

HQ city
Washington
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Marwood Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Transaction Support Advisory: Due diligence and advisory services for buy-side and sell-side healthcare M&A and financing transactions across provider, payor, HIT, life sciences and broader healthcare services sectors.
  2. Retained Services: Retainer-based advisory services providing real-time access to subject matter experts, policy and reimbursement trend analysis, on-demand insights, published research, and catalyst tracking for lenders, private equity, institutional investors and healthcare companies.
  3. Value Creation Services: Strategic advisory services for healthcare corporations and investors including policy analysis, market strategy, reimbursement consulting, compliance assessments, and operational performance improvement.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Marwood Group product offering

Product offering

Core offering

Marwood Group is a healthcare-focused advisory and consulting firm that delivers transaction support (buy-side and sell-side due diligence for healthcare M&A and financing), value creation (policy, market strategy, reimbursement, compliance, and operational advisory), and retained services (ongoing expert access, policy tracking, and on-demand insights) to private equity firms, healthcare companies, lenders, and institutional investors. Advisory work is grounded in a proprietary claims-based data module covering nearly 12 billion provider and payor records and supported by former government officials and industry operators with 20+ years of experience.

Product overview

Marwood Group is a healthcare advisory firm offering a comprehensive suite of consulting services organized around three core pillars: Transaction Support (due diligence for M&A), Value Creation (strategic advisory), and Retained Services (ongoing expert access). The firm's focus areas span Healthcare Policy, Market Research, Business Intelligence & Advanced Analytics (with a proprietary dataset of nearly 12 billion claims), Clinical Quality & Compliance, Performance Improvement, Life Sciences & HealthTech, Global Insights, and Financial Advisory (via its FINRA-registered affiliate). The firm also publishes The Healthcare Report (HCR), a curated newsletter reaching over 90,000 readers. These services are delivered by former government officials, healthcare operators, investment bankers, and industry experts to serve healthcare companies, private equity firms, lenders, and institutional investors.

Differentiator

Problem solved

Functional benefit

Products and services

  • Transaction Support Due diligence and advisory services for buy-side and sell-side M&A and financing transactions across the healthcare spectrum, supporting over $500B in transactions. Targeted at private equity firms, lenders, and healthcare companies evaluating or executing healthcare deals.
  • Value Creation Strategic advisory services combining healthcare policy expertise with operational and primary research capabilities to assess the healthcare industry and support portfolio companies. Targeted at healthcare corporations and investors seeking post-transaction value creation.
  • Retained Services Real-time access to dedicated subject matter experts and industry analysts for lenders, private equity, institutional investors, and healthcare companies, including policy tracking and risk management support on a recurring subscription basis.
  • Healthcare Policy Advisory Federal and state legislative and regulatory action analysis across all healthcare subsectors, staffed by former White House, executive branch agency, senior congressional staff and senior state Medicaid officials.
  • Market Research Integrated market research combining deep healthcare policy knowledge with primary research capabilities using a proprietary network of stakeholders across the healthcare spectrum.
  • Business Intelligence & Advanced Analytics Proprietary data module consisting of claims-based information with nearly 12 billion provider and payor claims across commercial, Medicare, and Medicaid, updated quarterly, providing code-specific benchmarking, reimbursement analyses, state-level profiles, and growth opportunity assessments for clients.
  • Clinical Quality & Compliance Clinical compliance assessments, consulting services, and revenue cycle management functionality assessments conducted by clinicians, former healthcare operators, and certified coding experts.
  • Performance Improvement Revenue enhancement, cost reduction, and operational transformation services for healthcare providers, including revenue cycle management optimization and billing system improvements.
  • Life Sciences & HealthTech Strategic guidance for investors, service providers, developers, and manufacturers of emerging healthcare innovations, including regulatory, reimbursement, and commercial strategy services.
  • Global Insights Multinational policy and market insights focusing on UK and EU regulatory, funding, and reimbursement dynamics, with international team members from Department of Health, NHS England, and private health insurers.
  • Financial Advisory Strategic transaction evaluation and execution through affiliate Marwood Group LLC, a FINRA-registered broker-dealer and state-registered investment adviser.
  • The Healthcare Report (HCR) Newsletter Marwood's curated healthcare newsletter with over 90,000 healthcare executives, thought leaders and stakeholders, providing coverage of trends, advancements, and insights across major healthcare segments.

Quantifiable outcome

  • $500B+ in transaction value supported
  • +3 more outcomes

Companies that use Marwood Group

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Marwood Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Marwood Group partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Marwood Group competitors and assessment

Company assessment

Direct peers

  • The Chartis Group: Healthcare-focused strategy and management consulting firm serving providers, payers, and investors across M&A, value-based care and performance improvement. Direct overlap with Marwood's healthcare advisory and value creation practices.
  • ECG Management Consultants: Boutique consultancy focused on healthcare providers, payers and integrated delivery systems, advising on strategy, M&A, reimbursement and performance. Highly comparable to Marwood's provider/payer transaction support and value creation work.
  • Kaufman Hall: Specialist advisor to healthcare organizations and investors on strategy, M&A and performance, with deep provider and capital markets expertise. Closely comparable to Marwood's M&A diligence and value creation offerings.
  • Guidehouse (formerly Navigant): Large advisory firm with a substantial healthcare practice serving providers, payers and life sciences clients on strategy, operations and M&A. Comparable in healthcare depth, larger in scale with broader public-sector reach.
  • Huron Consulting Group: US consulting firm with a strong healthcare practice covering strategy, operations and performance improvement for providers, payers and life sciences companies. Comparable in healthcare advisory focus and ability to support transaction-related workstreams.

Broad incumbents

  • ZS Associates: Global management consulting and analytics firm specializing in life sciences and healthcare, with proprietary data assets and operations/policy work. Overlaps with Marwood in healthcare advisory, life sciences and data-driven diligence.
  • Oliver Wyman: Global consulting firm with a large healthcare and life sciences practice advising payers, providers and investors on strategy, M&A and risk. Overlaps Marwood on healthcare transaction advisory but at far broader scale and across multiple sectors.
  • Bain & Company (Healthcare practice): Top-tier global consultancy with a dedicated healthcare practice advising PE sponsors, payers, providers and pharma on strategy and M&A. Competes with Marwood for healthcare strategy and diligence mandates but offers much larger global staffing.
  • McKinsey & Company (Healthcare practice): Top-tier global consultancy with a deep healthcare practice serving PE sponsors, payers, providers and pharma on strategy, diligence and value creation. Substantially larger than Marwood and competes on the largest healthcare mandates.

Emerging players

  • Analysis Group: Specialized economic, financial and healthcare analytics firm providing expert analysis for transactions, disputes and policy. Comparable to Marwood on healthcare-oriented analytics and testimony, though a much broader economics-rooted platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Marwood Group social profiles

Digital presence

Marwood Group compliance and trust

Trust signal

Compliance2 records

Marwood Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Marwood Group leadership team

Management profile

Number of profiles

Profiles20 records

Marwood Group subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Marwood Group funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Marwood Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Marwood Group

What does Marwood Group do?

Marwood Group is a healthcare-focused advisory and consulting firm that delivers transaction support (buy-side and sell-side due diligence for healthcare M&A and financing), value creation (policy, market strategy, reimbursement, compliance, and operational advisory), and retained services (ongoing expert access, policy tracking, and on-demand insights) to private equity firms, healthcare companies, lenders, and institutional investors. Advisory work is grounded in a proprietary claims-based data module covering nearly 12 billion provider and payor records and supported by former government officials and industry operators with 20+ years of experience.

Is Marwood Group a public or private company?

Marwood Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Marwood Group founded?

Marwood Group was founded in 2000. It employs 101 to 250 people.

Where is Marwood Group based?

Marwood Group is headquartered in Washington, United States, in the North America region.

How does Marwood Group make money?

Three revenue lines are on record. Transaction Support Advisory is the primary driver. The others are retained Services and value Creation Services.

Who are Marwood Group's main competitors?

Direct peers on record are The Chartis Group, ECG Management Consultants, Kaufman Hall, Guidehouse (formerly Navigant) and Huron Consulting Group. Broad incumbents are ZS Associates, Oliver Wyman, Bain & Company (Healthcare practice) and McKinsey & Company (Healthcare practice). Analysis Group is listed as an emerging player.

Does Marwood Group have an API?

No public API is recorded for Marwood Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Pulse 2.0Lee Equity Partners Invests In Healthcare Advisory Firm Marwood Group And Names Chris Librizzi As CEOLee Equity Partners invested in healthcare advisory firm Marwood Group, with financial terms undisclosed. The firm appointed Chris Librizzi as CEO and Richard Jeanneret as Executive Chairman. The capital is expected to support organic and acquisition-driven growth.Pulse 2.0Lee Equity Partners Invests In Marwood Group As Chris Librizzi Named CEOMarwood Group received a strategic investment from Lee Equity Partners, with financial terms undisclosed. Chris Librizzi, previously at EY-Parthenon, was named CEO, and Richard Jeanneret joined as Executive Chairman. The firm plans to use the partnership to expand with private equity firms and enter new client segments.PR NewswireMarwood Group Announces Strategic Investment from funds managed by Lee Equity Partners, LLC and Appointment of Chris Librizzi as CEOMarwood Group announced a strategic investment from Lee Equity Partners and appointed Chris Librizzi as CEO. The partnership will fund acquisitions, senior hires, and expansion into hospitals, payors, and life sciences. Librizzi joins from EY-Parthenon, with Richard Jeanneret as Executive Chairman.LinkedInMarwood Group Announces Strategic Investment from funds managed by Lee Equity Partners, LLC and Appointment of Chris Librizzi as CEOMarwood Group announced a strategic investment from funds managed by Lee Equity Partners and appointed Chris Librizzi as CEO. The partnership will support acquisitions and senior hires to expand capabilities. Marwood intends to leverage the investment to serve private equity firms and expand into hospitals, payors, and life sciences.PR NewswireIndependent Primary Care Physicians: How Will Election 2016 Affect You and Your Practice?Specialdocs Consultants is hosting a complimentary webinar on November 18, 2016, featuring Marwood Group healthcare policy experts Michael Gaffin and Joseph Mercer to discuss how Donald Trump's election and presidency may impact independent primary care physicians and healthcare reform.